BSTC BioSpecifics gains FDA Approval of sBLA for XIAFLEX® for the Concurrent Treatment of Two Dupuytren's Contracture Cords Good for them, they have been trading way above their M/A's hoot hoot, let's see what today brings for them http://finance.yahoo.com/news/biospecifics-technologies-corp-announces-fda-120000882.html stockcharts.com/c-sc/sc?s=BSTC&p=D&yr=0&mn=6&dy=0&i=p14244163321&r=1413894531068